iMediSync
iMediSync provides automatic brain wave analysis and neuromodulation solutions.
Funding reportedLast round: Series C
What company datasets say iMediSync raised
Funding, as reported
Reported in all15.6Bin the source's currency
Rounds6
Last roundSeries C
Last round dateJan 2022
Investors listed7
On a portfolio page
Investors who name them
Each firm lists iMediSync on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Analytics in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put iMediSync in front of investors. Or tell us what we have wrong.